HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Tuesday, 7 February 2017

Quarterly summary of ScHARR Reports

To help our readers keep track of what we do, we provide a monthly list of journal publications, news of new projects, quarterly summaries of our discussion papers and announcements of DSU reports.  To add to this, we are now producing a quarterly summary of all our public and third sector reports.  Here’s our first one, covering October – December 2016.  If you require any further information on any of these, contact the ScHARR Library.

  • Evolocumab for treating hyperlipidaemia and mixed dyslipidaemia (excluding homozygous familial hypercholesterolaemia) [ID765] (2016)
  • Cabazitaxel for treating hormone-relapsed metastatic prostate cancer after a docetaxel-containing regimen (review of TA255)[ID889] (2016)
  • Adalimumab for treating moderate to severe hidradenitis suppurativa [ID812] (2016)
  • The clinical and cost-effectiveness of the LightCycler SeptiFast Test MGRADE, SepsiTest and IRIDICA BAC BSI assay for rapidly identifying bloodstream bacteria and fungi: a systematic review and economic evaluation. (2016)

  • DSU report: The use of real world data for the estimation of treatment effects in NICE decision making (June 2016, updated December 2016)
  • TSD18: Methods for population-adjusted indirect comparisons in submissions to NICE (December 2016)

  • Mukuria C, Peasgood T, Rowen D, Brazier J.  An empirical comparison of well-being measures used in the UK.  Policy Research Unit in Economic Evaluation of Health and Care Interventions. Universities of Sheffield and York. EEPRU Research Report 048 (November 2016). 

  • Evaluating Self Management in Diabetes (ESMiD) Revised Final Report for the Health Foundation (April 2016). Sponsor: The Health Foundation
  • A model to evaluate the cost effectiveness of condom distribution (CD schemes), developed for NICE public health guidance on condom distribution schemes and sexually transmitted infections (STIs) May 2016. Sponsor: NICE